Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Turning liabilities into opportunities: Off-target based drug repurposing in cancer
Vinayak Palve, Yi Liao, Lily Rix, et al.
Seminars in Cancer Biology (2020) Vol. 68, pp. 209-229
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Overcoming cancer therapeutic bottleneck by drug repurposing
Zhe Zhang, Li Zhou, Na Xie, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 433
Network Pharmacology Approach for Medicinal Plants: Review and Assessment
Fatima Noor, Muhammad Tahir ul Qamar, Usman Ali Ashfaq, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 572-572
Open Access | Times Cited: 248
Artificial intelligence, machine learning, and drug repurposing in cancer
Ziaurrehman Tanoli, Markus Vähä‐Koskela, Tero Aittokallio
Expert Opinion on Drug Discovery (2021) Vol. 16, Iss. 9, pp. 977-989
Open Access | Times Cited: 124
Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy
Freya R. Weth, Georgia B. Hoggarth, Anya F. Weth, et al.
British Journal of Cancer (2023) Vol. 130, Iss. 5, pp. 703-715
Open Access | Times Cited: 73
Overcoming cancer therapy resistance: From drug innovation to therapeutics
Jinrui Wei, Meng‐Yi Lu, Tian‐Hua Wei, et al.
Drug Resistance Updates (2025) Vol. 81, pp. 101229-101229
Closed Access | Times Cited: 2
Drugs repurposed: An advanced step towards the treatment of breast cancer and associated challenges
Jonaid Ahmad Malik, Sakeel Ahmed, Bisma Jan, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112375-112375
Open Access | Times Cited: 76
The impact of the BCR-ABL oncogene in the pathology and treatment of chronic myeloid leukemia
Mohamed El‐Tanani, Hamdi Nsairat, Ismail Matalka, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155161-155161
Open Access | Times Cited: 15
Injectable Hydrogel To Deliver Bone Mesenchymal Stem Cells Preloaded with Azithromycin To Promote Spinal Cord Repair
Yujie Wan, Yan Lin, Tan Xie, et al.
ACS Nano (2024) Vol. 18, Iss. 12, pp. 8934-8951
Closed Access | Times Cited: 13
Drug Repurposing: A Leading Strategy for New Threats and Targets
Ashish Sriram Mishra, Manimaran Vasanthan, Sivakumar Ponnurengam Malliappan
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 4, pp. 915-932
Open Access | Times Cited: 12
Improving drug repositioning with negative data labeling using large language models
Milan Picard, Mickaël Leclercq, Antoine Bodein, et al.
Journal of Cheminformatics (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?
Christina Pfab, Luisa Schnobrich, Samir Eldnasoury, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3193-3193
Open Access | Times Cited: 54
Pathway-Based Drug-Repurposing Schemes in Cancer: The Role of Translational Bioinformatics
Enrique Hernández-Lemus, Mireya Martínez-García
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 42
Repurposing antifungal drugs for cancer therapy
Ningna Weng, Zhe Zhang, Yunhan Tan, et al.
Journal of Advanced Research (2022) Vol. 48, pp. 259-273
Open Access | Times Cited: 29
The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation
Fan Luo, Han Li, Wenjuan Ma, et al.
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 1, pp. 60-79
Open Access | Times Cited: 22
Recent progress in covalent organic frameworks for cancer therapy
Nabab Khan, Garima Slathia, Kajal Kaliya, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 6, pp. 103602-103602
Closed Access | Times Cited: 20
Current trends and future prospects of drug repositioning in gastrointestinal oncology
Nayeralsadat Fatemi, Mina Karimpour, Hoda Bahrami, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 6
DrugMAP 2.0: molecular atlas and pharma-information of all drugs
Fengcheng Li, Minjie Mou, LI Xiao-yi, et al.
Nucleic Acids Research (2024) Vol. 53, Iss. D1, pp. D1372-D1382
Open Access | Times Cited: 6
Drug Repurposing: A Strategy for Discovering Inhibitors against Emerging Viral Infections
Igor José dos Santos Nascimento, Thiago Mendonça de Aquino, Edeildo Ferreira da Silva‐Júnior
Current Medicinal Chemistry (2020) Vol. 28, Iss. 15, pp. 2887-2942
Closed Access | Times Cited: 35
The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitors
Vinayak Palve, Claire E. Knezevic, Daniel S. Bejan, et al.
Cell chemical biology (2021) Vol. 29, Iss. 2, pp. 202-214.e7
Open Access | Times Cited: 32
Virtual screening and molecular dynamics simulation approach for the identification of potential multi-target directed ligands for the treatment of Alzheimer’s disease
Kailash Jangid, Bharti Devi, Ashrulochan Sahoo, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 1, pp. 509-527
Closed Access | Times Cited: 12
Therapeutic Target Identification and Drug Discovery Driven by Chemical Proteomics
Mingjie Zou, Zhou Haiyuan, Letian Gu, et al.
Biology (2024) Vol. 13, Iss. 8, pp. 555-555
Open Access | Times Cited: 4
Comprehensive applications of the artificial intelligence technology in new drug research and development
Hongyu Chen, Dong Xin Lu, Ziyi Xiao, et al.
Health Information Science and Systems (2024) Vol. 12, Iss. 1
Closed Access | Times Cited: 4
Machine learning for drug repositioning: Recent advances and challenges
Lijun Cai, Jiaxin Chu, Junlin Xu, et al.
Current Research in Chemical Biology (2023) Vol. 3, pp. 100042-100042
Open Access | Times Cited: 10
Study on the Mechanism of Action of the Pt(IV) Complex with Lonidamine Ligands by Ultrafast Chemical Proteomics
Ekaterina A.. Imaikina, Ivan I. Fedorov, Daria D. Emekeeva, et al.
ACS Pharmacology & Translational Science (2025)
Open Access
The Missing Enzymes: A Call to Update Pharmacological Profiling Practices for Better Drug Safety Assessment
Monika Maciąg, Vardan T. Karamyan
Journal of Medicinal Chemistry (2025)
Open Access
Page 1 - Next Page

Scroll to top